CLINICAL

Popular insulin meets target in real-world studyNovo Nordisk’s DEVOTE study reveals interesting findings.
New universal companion diagnostic paves the way for precision oncologyFDA approves new diagnostic test for non-small cell lung cancer.
New antibiotic approved for acute bacterial skin infectionsFDA approved the use of a new fluoroquinolone antibiotic to treat ABSSSI.
FDA approves Bayer’s Bluetooth-enabled auto-injector for multiple sclerosisFDA has approved a supplemental Biologics License Application (sBLA) for Bayer’s myBETAapp and BETACONNECT Navigator for multiple sclerosis (MS) patients
FDA to drug maker: Pull opioid pain drugPotential public health consquences prompts FDA to request removal of opioid pain medication.
FDA approves first generic Truvada for HIVThe first generic Truvada for treating and preventing HIV will be available, but when?
FDA gives once-daily HIV therapy go-aheadFDA approves Isentress at a higher dose for HIV-1 infected patients.
Asthma biologic may reduce oral steroid useA new trial for AstraZeneca’s benralizumab shows promising results for severe asthma patients.
First generic Strattera for ADHD approvedFDA has approved the first generic versions of Strattera (atomoxetine) for the treatment of attention deficit/hyperactivity disorder.
Investigational drug appears beneficial in preventing migrainesLilly's galcanezumab proves successful in three phase 3 migraine studies. Here are the findings.

Poll

View Results